BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21218608)

  • 1. C-reactive protein in acute pulmonary embolism.
    Abul Y; Karakurt S; Ozben B; Toprak A; Celikel T
    J Investig Med; 2011 Jan; 59(1):8-14. PubMed ID: 21218608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.
    Binder L; Pieske B; Olschewski M; Geibel A; Klostermann B; Reiner C; Konstantinides S
    Circulation; 2005 Sep; 112(11):1573-9. PubMed ID: 16144990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular dysfunction in acute pulmonary embolism: NT-proBNP vs. troponin T.
    Cotugno M; Orgaz-Molina J; Rosa-Salazar V; Guirado-Torrecillas L; García-Pérez B
    Med Clin (Barc); 2017 Apr; 148(8):339-344. PubMed ID: 28131517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.
    Ozsu S; Karaman K; Mentese A; Ozsu A; Karahan SC; Durmus I; Oztuna F; Kosucu P; Bulbul Y; Ozlu T
    Thromb Res; 2010 Dec; 126(6):486-92. PubMed ID: 20920821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
    Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
    Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic values of GDF-15 in comparison with NT-proBNP in patients with normotensive acute pulmonary embolism.
    Duran L; Kayhan S; Guzel A; Ince M; Kati C; Akdemir HU; Yavuz Y; Zengin H; Okuyucu A; Murat N
    Clin Lab; 2014; 60(8):1365-71. PubMed ID: 25185423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
    Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NT-proBNP for risk stratification of pulmonary embolism].
    Dores H; Fonseca C; Leal S; Rosário I; Abecasis J; Monge J; Correia MJ; Bronze L; Leitão A; Arroja I; Aleixo A; Silva A
    Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helical computerized tomography and NT-proBNP for screening of right ventricular overload on admission and at long term follow-up of acute pulmonary embolism.
    Laiho MK; Harjola VP; Graner M; Piilonen A; Raade M; Mustonen P
    Scand J Trauma Resusc Emerg Med; 2012 May; 20():33. PubMed ID: 22559861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team.
    Chen YL; Wright C; Pietropaoli AP; Elbadawi A; Delehanty J; Barrus B; Gosev I; Trawick D; Patel D; Cameron SJ
    J Thromb Thrombolysis; 2020 Jan; 49(1):34-41. PubMed ID: 31375993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX in the prediction of right ventricular dysfunction in patients with hemodynamically stable acute pulmonary embolism.
    Abul Y; Ozsu S; Mentese A; Durmus I; Bektas H; Pehlivanlar M; Turan OE; Sumer A; Orem A; Ozlu T
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):838-43. PubMed ID: 23613041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism.
    Vuilleumier N; Limacher A; Méan M; Choffat J; Lescuyer P; Bounameaux H; Aujesky D; Righini M
    J Intern Med; 2015 Jun; 277(6):707-16. PubMed ID: 25285747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional right ventricular dysfunction in acute pulmonary embolism: relationship with clot burden and biomarker profile.
    Tuzovic M; Adigopula S; Amsallem M; Kobayashi Y; Kadoch M; Boulate D; Krishnan G; Liang D; Schnittger I; Fleischmann D; McConnell MV; Haddad F
    Int J Cardiovasc Imaging; 2016 Mar; 32(3):389-98. PubMed ID: 26428674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides in acute pulmonary embolism: a systematic review.
    Cavallazzi R; Nair A; Vasu T; Marik PE
    Intensive Care Med; 2008 Dec; 34(12):2147-56. PubMed ID: 18626627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of serum cardiac biomarkers for right ventricular dysfunction in non-high-risk patients with acute pulmonary thromboembolism].
    Liu FF; Gong JN; Jiang Y; Kuang TG; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):847-852. PubMed ID: 30423626
    [No Abstract]   [Full Text] [Related]  

  • 18. N-terminal Pro-B type natriuretic peptide as long-term predictor of death after an acute pulmonary embolism.
    Alonso-Martínez JL; Annicchérico-Sánchez FJ; Urbieta-Echezarreta MA; Pérez-Ricarte S
    Med Clin (Barc); 2015 Mar; 144(6):241-6. PubMed ID: 24947203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism.
    Pruszczyk P; Kostrubiec M; Bochowicz A; Styczyński G; Szulc M; Kurzyna M; Fijałkowska A; Kuch-Wocial A; Chlewicka I; Torbicki A
    Eur Respir J; 2003 Oct; 22(4):649-53. PubMed ID: 14582919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.